I dette studie randomiseredes 255 patienter til behandling med Xeloda (1250 mg/ m2 to gange dagligt i 2 uger efterfulgt af en uges pause og behandling med docetaxel 75 mg/ m2 som 1 times intravøs infusion hver 3. uge).
In this trial, 255 patients were randomised to treatment with Xeloda (1250 mg/ m2 twice daily for 2 weeks followed by 1-week rest period and docetaxel 75 mg/ m2 as a 1 hour intravenous infusion every 3 weeks).